Pharmaceutical manufacturer JCR Pharma has donated a total of 100 million shares to Kyoto University's Tasuku Honjo Volunteer Fund and Cancer Immunotherapy Research Fund through a third-party allotment of treasury shares.Kyoto University will use the dividend, which is estimated to be about 2,000 million yen a year, for training young researchers.
According to Kyoto University, the distribution of donated shares is 50 shares for each fund. Converting to December 12 stocks, the market price of 5 million shares is equivalent to about 100 billion yen.The Tasuku Honjo Volunteer Fund was established by Professor Tasuku Honjo of Kyoto University, who received the Nobel Prize in Physiology or Medicine, to foster young researchers. there is
A press conference for the presentation was held at Kyoto University Centennial Clock Tower International Exchange Hall in Yoshida Honmachi, Sakyo Ward, Kyoto City. presented a letter of appreciation.
Distinguished Professor Honjo expressed his gratitude, stating that this donation will create a new cooperative relationship between universities and companies, and that the stable income from dividends will greatly help foster young researchers and advance cancer immunology research. .
